{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:04:43Z","timestamp":1780355083798,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.ajo.2007.09.023","type":"journal-article","created":{"date-parts":[[2008,1,18]],"date-time":"2008-01-18T07:13:23Z","timestamp":1200640403000},"page":"5-11.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Characteristics of Untreated AIDS-related Cytomegalovirus Retinitis. I. Findings before the Era of Highly Active Antiretroviral Therapy (1988 to 1994)"],"prefix":"10.1016","volume":"145","author":[{"given":"Gary N.","family":"Holland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean D.","family":"Vaudaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M.","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina-Caren","family":"Folz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Cumberland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin A.","family":"McCannel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Helm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. David","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2007.09.023_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajo.2007.09.040","article-title":"Characteristics of untreated, AIDS-related cytomegalovirus retinitis: II. Findings in the era of highly active antiretroviral therapy HAART (1997 to 2000)","volume":"145","author":"Holland","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1076\/ocii.7.3.179.4000","article-title":"New strategies for the management of AIDS-related CMV retinitis in the era of potent antiretroviral therapy","volume":"7","author":"Holland","year":"1999","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2007.09.023_bib3","first-page":"1088","article-title":"Cytomegalovirus diseases","volume":"72","author":"Holland","year":"1996"},{"key":"10.1016\/j.ajo.2007.09.023_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archopht.1964.00970020046011","article-title":"Retinal involvement in adult cytomegalic inclusion disease","volume":"72","author":"Smith","year":"1964","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0161-6420(83)80009-8","article-title":"Acquired immune deficiency syndrome","volume":"90","author":"Holland","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.023_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0161-6420(85)34008-3","article-title":"Acquired immune deficiency syndrome","volume":"92","author":"Pepose","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.023_bib7","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2007.09.023_bib8","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajo.2007.09.023_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_bib10","first-page":"141","article-title":"Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group","volume":"124","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_bib11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-109-12-963","article-title":"The diagnosis of cytomegalovirus retinitis","volume":"109","author":"Bloom","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajo.2007.09.023_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0161-6420(87)33454-2","article-title":"Cytomegalovirus retinitis and response to therapy with ganciclovir","volume":"94","author":"Henderly","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.023_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/infdis\/164.4.777","article-title":"Suppression of cytomegalovirus retinitis in persons with AIDS with high-dose intravenous acyclovir","volume":"164","author":"Sha","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajo.2007.09.023_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0002-9394(88)90239-5","article-title":"Atypical retinitis in patients with the acquired immunodeficiency syndrome","volume":"105","author":"Fay","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_bib15","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archopht.1989.01070010890037","article-title":"Regression of cytomegalovirus retinitis with zidovudine","volume":"107","author":"Guyer","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_bib16","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archopht.1988.01060140328016","article-title":"Resolution of cytomegalovirus retinitis with zidovudine therapy: case report","volume":"106","author":"D\u2019Amico","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_bib17","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archopht.1992.01080220097029","article-title":"Progression rates of cytomegalovirus retinopathy in ganciclovir- treated and untreated patients","volume":"110","author":"Holland","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_bib18","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/archopht.1989.01070020841024","article-title":"A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy","volume":"107","author":"Holland","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_bib19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0161-6420(87)33534-1","article-title":"Treatment of cytomegalovirus retinopathy with ganciclovir","volume":"94","author":"Holland","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.023_bib20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0161-6420(87)33535-3","article-title":"Treatment of cytomegalovirus retinitis with ganciclovir","volume":"94","author":"Jabs","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.023_bib21","first-page":"1250","article-title":"Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group","volume":"101","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.023_bib22","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1073\/pnas.84.23.8642","article-title":"Immediate-early gene region of human cytomegalovirus transactivates the promoter of human immunodeficiency virus","volume":"84","author":"Davis","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajo.2007.09.023_bib23","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/infdis\/157.3.508","article-title":"Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus","volume":"157","author":"Skolnik","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajo.2007.09.023_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/513804","article-title":"A randomized, double-blind trial of valacyclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection","volume":"177","author":"Feinberg","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajo.2007.09.023_bib25","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJM199606063342302","article-title":"Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS","volume":"334","author":"Spector","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2007.09.023_fr1","first-page":"S1","article-title":"Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome","volume":"36","year":"1987","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajo.2007.09.023_fr2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0002-9394(14)78239-X","article-title":"Signs and symptoms of uveitis","volume":"47","author":"Hogan","year":"1959","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_fr3","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1167\/iovs.06-0138","article-title":"Hemorheologic abnormalities associated with HIV infection: in vivo assessment of retinal microvascular blood flow","volume":"47","author":"Dadgostar","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2007.09.023_fr4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archopht.1992.01080220097029","article-title":"Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients","volume":"110","author":"Holland","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_fr5","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/archopht.1989.01070020841024","article-title":"A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy","volume":"107","author":"Holland","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_fr6","first-page":"141","article-title":"Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group","volume":"124","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_fr7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-109-12-963","article-title":"The diagnosis of cytomegalovirus retinitis","volume":"109","author":"Bloom","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajo.2007.09.023_fr8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-93-5-664","article-title":"Cytomegalovirus retinitis in immunosuppressed hosts","volume":"93","author":"Egbert","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajo.2007.09.023_fr9","article-title":"An update on AIDS-related cytomegalovirus retinitis","volume":"Vol IX","author":"Holland","year":"1991"},{"key":"10.1016\/j.ajo.2007.09.023_fr10","first-page":"1250","article-title":"Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group","volume":"101","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.023_fr11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0161-6420(87)33454-2","article-title":"Cytomegalovirus retinitis and response to therapy with ganciclovir","volume":"94","author":"Henderly","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.023_fr12","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archopht.118.9.1196","article-title":"Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome","volume":"118","author":"Holbrook","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_fr13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0161-6420(85)34008-3","article-title":"Acquired immune deficiency syndrome","volume":"92","author":"Pepose","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.023_fr14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00126334-200004150-00013","article-title":"Routine ophthalmologic screening for cytomegalovirus retinitis in patients with AIDS","volume":"23","author":"Wohl","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajo.2007.09.023_fr15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9394(14)71453-9","article-title":"Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome","volume":"115","author":"Kuppermann","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_fr16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00042560-199511000-00004","article-title":"Evidence of active cytomegalovirus infection in clinically stable HIV-infected individuals with CD4+ lymphocyte counts below 100\/microliters of blood: features and relation to risk of subsequent CMV retinitis","volume":"10","author":"MacGregor","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.ajo.2007.09.023_fr17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0161-6420(01)00878-8","article-title":"An analysis of lesion size and location in newly diagnosed cytomegalovirus retinitis","volume":"109","author":"Sarrafizadeh","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.023_fr18","first-page":"111","article-title":"Role of retinal vascular endothelial cells in development of CMV retinitis","volume":"96","author":"Rao","year":"1998","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2007.09.023_fr19","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.ophtha.2004.03.001","article-title":"Clinical risk factors for cytomegalovirus retinitis in patients with AIDS","volume":"111","author":"Hodge","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.023_fr20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0002-9394(14)75980-X","article-title":"Hemorheologic abnormalities in patients with human immunodeficiency virus infection and ophthalmic microvasculopathy","volume":"109","author":"Engstrom","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_fr21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1442-9071.1996.tb01552.x","article-title":"A foveal-sparing pattern of cytomegalovirus retinitis in the acquired immunodeficiency syndrome","volume":"24","author":"Luckie","year":"1996","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_fr22","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archopht.1996.01100140048006","article-title":"Acquired immunodeficiency syndrome-associated herpes simplex virus retinitis","volume":"114","author":"Cunningham","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.09.023_fr23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0161-6420(94)31142-0","article-title":"The progressive outer retinal necrosis syndrome","volume":"101","author":"Engstrom","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.09.023_fr24","first-page":"1181","article-title":"A microscopic study of herpes simplex virus retinopathy in mice","volume":"28","author":"Holland","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2007.09.023_fr25","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0161-6420(84)34201-4","article-title":"Ophthalmic involvement in acquired immunodeficiency syndrome","volume":"91","author":"Palestine","year":"1984","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293940700846X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293940700846X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:55:47Z","timestamp":1757595347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293940700846X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S000293940700846X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2007.09.023","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Untreated AIDS-related Cytomegalovirus Retinitis. I. Findings before the Era of Highly Active Antiretroviral Therapy (1988 to 1994)","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2007.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}